i know we'll talk ton you soon. >> it's a pleasure. >> josh reeves.en payroll. the ceo of gusto. >> when we come back, the nasdaq bio tech index. i love you. love you too. ♪ one minute. ♪ hi. hi dad. we need to do this. letting go... it's a little easier when you've saved for college, with state farm. >>> bio tech's falling on a pretty good tape and a lot of today's decline might be in thanks to hillary clinton. >> just about 45 minutes, maybe an hour ago, we started to see the index take a hit. that's right around the same time, down 2.6% now. that's right around the time hillary clinton tweeted out a "new york times" story about a drug whose price was increased 5,000 percent after its company touring pharmaceuticals acquired it. without really changing the drug at all. she tweeted a link to that story and said price gouging like this in the specialty drug market is outrageo outrageous. tomorrow, i'll lay out a plan to take it on. now, i've been talking with analysts and industry experts today who have been saying that hillary clinton's candidacy cou